OccamzRazor
OccamzRazor: Unveiling Parkinson's Disease treatments through dynamic machine learning mapping.
Founded
2015OccamzRazor: Unveiling Parkinson's Disease treatments through dynamic machine learning mapping.
OccamzRazor was founded with the mission to revolutionize drug discovery through advanced machine learning techniques. The company's core vision is to map the human brain's aging process, starting with Parkinson's Disease, to uncover hidden mechanisms and develop new treatments. They offer innovative digital science solutions that create dynamic knowledge maps, providing deeper insights into neurodegenerative diseases. OccamzRazor focuses on leveraging cutting-edge technology to address the complexities of brain aging and improve patient outcomes.
Notable figures associated with OccamzRazor include experts in machine learning, neuroscience, and pharmacology, who bring a wealth of knowledge and experience to the company. The startup has attracted significant interest from investors focused on healthcare innovation. Key achievements include the development of their proprietary dynamic mapping technology, which has shown promise in identifying novel treatment pathways for Parkinson’s Disease. Overall, OccamzRazor is making a substantial impact in the field of neurodegenerative disease research, aiming to transform how these conditions are understood and treated.
Companies similar to OccamzRazor include Spring Discovery, TorMagnus Pharmaceuticals, NeuroX1 and Cognaisent.
OccamzRazor was founded in 2015.
OccamzRazor's headquarters is located in San Francisco, CA, US.
OccamzRazor's most recent funding round was for $6.1M (USD) in March 2022.
As of Mar 8, 2022, OccamzRazor has disclosed funding of $12.4M (USD). Undisclosed round amounts are excluded.
OccamzRazor has 35 employees as of Feb 4, 2024.
cognaisent.com
